IRS1 and Insulin resistance: IL-6 also reduces the expression of IRS-1 and glucose transporter-4 (100), and administration of IL-6–neutralizing antibodies improved insulin resistance in IkB kinase-β transgenic mice with constitutively activated signaling of NF-k Band hyperglycemia (98).